Elizabeth Leef Jacobson, M.D.
Dr. Elizabeth Leef Jacobson graduated from Bryn Mawr College in 1983 and received her medical degree from the University of Medicine and Dentistry of New Jersey- Robert Wood Johnson Medical School in 1990. She completed her internship and residency at Lenox Hill Hospital and her Allergy and Immunology fellowship training at New York Presbyterian Hospital-Cornell in 1995.
Dr. Jacobson was appointed Assistant Professor of Medicine at Weill Medical College of Cornell University in 1996 and Assistant Attending Physician at New York Presbyterian Hospital in 1995. She practices at the Iris Cantor Women's Health Center, a multidisciplinary practice providing comprehensive, coordinated care to both women and men.
Dr. Jacobson directs a Women's Health elective for fourth-year medical students and participates in the Introductory Clerkship and Medicine, Patients and Society courses for first- and second-year medical students.
Dr. Jacobson is a diplomat of the American Board of Internal Medicine and the American Board of Allergy and Immunology. She is a member of the American College of Physicians.
Insurance Plans Accepted
The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.
- Aetna - Weill Cornell [POS]
- Empire Blue Cross/Blue Shield [EPO]
- Empire Blue Cross/Blue Shield [HMO]
- Empire Blue Cross/Blue Shield [Mediblue (Senior)]
- Empire Blue Cross/Blue Shield [PPO]
- Rockefeller University - CoreSource
Smith KA, Jacobson EL, Sohn T, Warren D, Emert R, Giordano M. In vivo assessment of antiviral reactivity in chronic HIV infection. HIV Clin Trials. 2000 Nov-Dec;1(3):16-22.
Lalezari JP, Beal JA, Ruane PJ, Cohen CJ, Jacobson EL, Sundin D, Leong WP, Raffanti SP, Wheeler DA, Anderson RD, Keiser P, Schrader SR, Goodgame JC, Steinhart CR, Murphy RL, Wolin MJ, Smith KA. Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV patients: a randomized controlled trial. HIV Clin Trials. 2000 Nov-Dec;1(3):1-15.
Smith KA, Jacobson EL, Emert R, Giordano M, Kovacs E, Mumneh N, Pilaro F, Sohn T, Warren D. Restoration of immunity with interleukin-2 therapy.AIDS Read. 1999 Nov;9(8):563-72.
Jacobson EL, Pilaro F, Smith KA Interleukin-2 infusions in HIV-infected patients.N Engl J Med. 1997 Apr 24;336(17):1260-1.
Jacobson EL, Pilaro F, Smith KA Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10405-10.
Glesby MJ, Bassett R, Alston-Smith B, Fichtenbaum C, Jacobson EL, Brass C, Owens S, Sulkowski M, Race EM, Sherman KE; AIDS Clinical Trials Group A5088 Protocol Team. Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. J Infect Dis. 2005 Mar 1;191(5):686-93. Epub 2005 Jan 26
Honors and Awards
2008-Excellence in Teaching award-Weill Medical College
- Allergy and Immunology
- Allergic Rhinitis
- Women's Health
Contact and Practices
- Allergy and Immunology
- Internal Medicine
- A.B., Bryn Mawr College, 1983
- M.D., Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 1990